Researchers Discover How HIV Affects White Matter in the Brain
Published on
The study may lead to new therapies that reverse the effects of white matter loss due to the virus.
Published on
The study may lead to new therapies that reverse the effects of white matter loss due to the virus.
Published on
CHOP is the only center to capture standardized clinical data from ongoing patient care.
Published on
CHOP is one of 15 partner clinics chosen for their expertise at treating the neurodevelopmental disorder.
Published on
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Published on
More than 400 patients with SCN2A-related disorders described in literature have genetic and clinical data mapped.
Published on
The Friedreich’s Ataxia Center of Excellence at CHOP was awarded $1.275 million by the Friedreich’s Ataxia Research Alliance, Hamilton and Finneran families and the CureFA Foundation
Published on
Ingo Helbig will use award to fund research addressing critical gaps of understanding in neurodevelopmental disorders at a genomic level.
Published on
A JAK inhibitor helped patients with Aicardi-Goutières Syndrome meet important developmental milestones.
Published on
We saw great clinical and research growth in our first year in operation, despite the challenges of the COVID-19 pandemic.
Published on
In an effort to expand access to continuous EEG (CEEG) monitoring, CHOP recently initiated a pilot program of remote CEEG monitoring for at-risk neonates at two regional affiliated hospitals that provide neonatology services.